205 related articles for article (PubMed ID: 8101767)
1. Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Bonsing BA; Devilee P; Cleton-Jansen AM; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
Cancer Res; 1993 Aug; 53(16):3804-11. PubMed ID: 8101767
[TBL] [Abstract][Full Text] [Related]
2. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.
Beerman H; Smit VT; Kluin PM; Bonsing BA; Hermans J; Cornelisse CJ
Cytometry; 1991; 12(2):147-54. PubMed ID: 1646701
[TBL] [Abstract][Full Text] [Related]
5. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Bonsing BA; Corver WE; Fleuren GJ; Cleton-Jansen AM; Devilee P; Cornelisse CJ
Genes Chromosomes Cancer; 2000 Jun; 28(2):173-83. PubMed ID: 10825002
[TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
7. Evidence of clonal divergence in colorectal carcinoma.
Tollenaar RA; Bonsing BA; Kuipers-Dijkshoorn NJ; Hermans J; van de Velde CJ; Cornelisse CJ; Fleuren GJ
Cancer; 1997 Apr; 79(7):1304-14. PubMed ID: 9083151
[TBL] [Abstract][Full Text] [Related]
8. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
[TBL] [Abstract][Full Text] [Related]
9. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of primary lung carcinomas and their lymph node metastases.
Volm M; Mattern J; Vogt-Schaden M; Wayss K
Anticancer Res; 1987; 7(1):71-6. PubMed ID: 3032072
[TBL] [Abstract][Full Text] [Related]
11. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
Lamb RF; Going JJ; Pickford I; Birnie GD
Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
[TBL] [Abstract][Full Text] [Related]
14. High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.
Bonsing BA; Beerman H; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
Cancer; 1993 Jan; 71(2):382-91. PubMed ID: 8422632
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
16. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.
Ellsworth RE; Ellsworth DL; Neatrour DM; Deyarmin B; Lubert SM; Sarachine MJ; Brown P; Hooke JA; Shriver CD
Mol Cancer Res; 2005 Feb; 3(2):71-7. PubMed ID: 15755873
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy analysis and cytologic examination of sorted cell populations from human breast tumors.
Cornelisse CJ; Tanke HJ; de Koning H; de la Riviere GB
Anal Quant Cytol; 1983 Sep; 5(3):173-83. PubMed ID: 6651016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
